Physician profile
Erin E Dodson
NPI 1407170103
$1,568.91
in general payments reported to CMS, 2019-2025
10 companies · $36.52 in 2025
The $36.52 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $412 · 2021: $669 · 2023: $89.37 · 2024: $49.28 · 2025: $36.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,257.13 | 2019-2025 | Puraply, Via Matrix, Novachor |
| Paragon 28, INC. | $94.21 | 2021 | |
| Integra Lifesciences Corporation | $55.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $36.54 | 2019-2023 | Tapestry |
| Melinta Therapeutics, LLC | $29.13 | 2019 | |
| Smith+Nephew, INC. | $27.08 | 2019-2024 | Collagenase Santyl |
| Convatec INC. | $22.59 | 2023 | |
| Nevro Corp. | $16.61 | 2021 | |
| Merck Sharp & Dohme LLC | $16.22 | 2019 | |
| Abbvie INC. | $13.46 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Dodson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.